M. Wijsenbeek (Rotterdam, Netherlands), S. Hart (Cottingham, United Kingdom), C. Albera (Orbassano (To), Italy), M. Funke-Chambour (Bern, Switzerland)
Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases d. eid (Egypt, Egypt)
| |
Interstitial lung abnormalities in smokers are associated with increased mortality N. Hoyer (København S, Denmark)
| |
Clinical significance of combined pulmonary fibrosis and emphysema H. Lee (Incheon, Republic of Korea)
| |
Does enhanced respiratory support affect clinical outcomes in ILD Patients with acute Respiratory failure? A. Achaiah (Portsmouth, United Kingdom)
| |
Correlation between lung sounds and HRCT signs of pulmonary fibrosis: a blinded prospective study. G. Sgalla (Modena, Italy)
| |
Transbronchial biopsy adequacy and sample size in a multidisciplinary team approach to interstitial lung disease diagnosis: one-year Padova experience F. Lunardi (Padova, PD, Italy)
| |
Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features M. Sterclova (Praha, Czech Republic)
| |
Romanian Registry for Interstitial Lung Diseases (REGIS): inclusion of patients in 3 years I. Strambu (Bucuresti 5, Romania)
| |
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF) M. Bonini (London, United Kingdom)
| |
Clubbing in patients with fibrotic interstitial lung diseases M. van Manen (Rotterdam, Netherlands)
| |
Combined pulmonary fibrosis and emphysema (CPFE): How does cohabitation affect respiratory functions? F. Çiftci (Ankara, Turkey)
| |
Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location M. Sarasate Azkona (Barcelona, Spain)
| |
Ultrasonographic features of typical HRCT signs of interstitial lung diseases A. Cui (Beijing, China)
| |
EXHALED NITRIC OXIDE MEASUREMENTS IN PATIENTS WITH ACUTE-ONSET INTERSTITIAL LUNG DISEASE K. Oishi (Ube, Japan)
| |
Spectrum of diffuse parenchymal lung diseases at a tertiary care center in India D. Behera (Chandigarh (U.T.), India)
| |
The role of transbronchial biopsy (TBB) in the multidisciplinary diagnosis of interstitial lung disease (ILD) F. Fracasso (Isola Vicentina, Italy)
| |
Hypoxic challange test (HCT) in patients with interstitial lund disease (ILD) M. Thirumaran (Wakefield, United Kingdom)
| |
Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease P. Cameli (Certaldo, Italy)
| |
Epidemiological profile of chronic interstitial lung diseases in Tunisian patients S. Aouadi (Ariana, Tunisia)
| |
Bronchoalveolar lavage fluid protein concentrations define phenotipically distinct populations within group of patients with hypersensitivity pneumonitis (HP) P. Paluch (Praha, Czech Republic)
| |